Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 5
2004 3
2005 1
2006 3
2007 6
2008 2
2009 2
2010 4
2011 8
2012 5
2013 11
2014 5
2015 6
2016 8
2017 6
2019 2
2020 4
Text availability
Article attribute
Article type
Publication date

Search Results

76 results
Results by year
Filters applied: . Clear all
Page 1
Melflufen - a peptidase-potentiated alkylating agent in clinical trials.
Wickström M, Nygren P, Larsson R, Harmenberg J, Lindberg J, Sjöberg P, Jerling M, Lehmann F, Richardson P, Anderson K, Chauhan D, Gullbo J. Wickström M, et al. Among authors: gullbo j. Oncotarget. 2017 Jun 8;8(39):66641-66655. doi: 10.18632/oncotarget.18420. eCollection 2017 Sep 12. Oncotarget. 2017. PMID: 29029544 Free PMC article. Review.
Eradicating Quiescent Tumor Cells by Targeting Mitochondrial Bioenergetics.
Zhang X, De Milito A, Demiroglu-Zergeroglu A, Gullbo J, D'Arcy P, Linder S. Zhang X, et al. Among authors: gullbo j. Trends Cancer. 2016 Nov;2(11):657-663. doi: 10.1016/j.trecan.2016.10.009. Epub 2016 Nov 11. Trends Cancer. 2016. PMID: 28741504 Review.
Targeting Mitochondrial Function to Treat Quiescent Tumor Cells in Solid Tumors.
Zhang X, de Milito A, Olofsson MH, Gullbo J, D'Arcy P, Linder S. Zhang X, et al. Among authors: gullbo j. Int J Mol Sci. 2015 Nov 13;16(11):27313-26. doi: 10.3390/ijms161126020. Int J Mol Sci. 2015. PMID: 26580606 Free PMC article. Review.
Analysis of determinants for in vitro resistance to the small molecule deubiquitinase inhibitor b-AP15.
Mofers A, Perego P, Selvaraju K, Gatti L, Gullbo J, Linder S, D'Arcy P. Mofers A, et al. Among authors: gullbo j. PLoS One. 2019 Oct 22;14(10):e0223807. doi: 10.1371/journal.pone.0223807. eCollection 2019. PLoS One. 2019. PMID: 31639138 Free PMC article.
Melflufen: A Peptide-Drug Conjugate for the Treatment of Multiple Myeloma.
Mateos MV, Bladé J, Bringhen S, Ocio EM, Efebera Y, Pour L, Gay F, Sonneveld P, Gullbo J, Richardson PG. Mateos MV, et al. Among authors: gullbo j. J Clin Med. 2020 Sep 27;9(10):3120. doi: 10.3390/jcm9103120. J Clin Med. 2020. PMID: 32992506 Free PMC article. Review.
Inhibition of proteasome deubiquitinase activity: a strategy to overcome resistance to conventional proteasome inhibitors?
Selvaraju K, Mazurkiewicz M, Wang X, Gullbo J, Linder S, D'Arcy P. Selvaraju K, et al. Among authors: gullbo j. Drug Resist Updat. 2015 Jul-Aug;21-22:20-9. doi: 10.1016/j.drup.2015.06.001. Epub 2015 Jul 6. Drug Resist Updat. 2015. PMID: 26183292 Free article. Review.
A novel tumor spheroid model identifies selective enhancement of radiation by an inhibitor of oxidative phosphorylation.
Karlsson H, Senkowski W, Fryknäs M, Mansoori S, Linder S, Gullbo J, Larsson R, Nygren P. Karlsson H, et al. Among authors: gullbo j. Oncotarget. 2019 Sep 3;10(51):5372-5382. doi: 10.18632/oncotarget.27166. eCollection 2019 Sep 3. Oncotarget. 2019. PMID: 31523395 Free PMC article.
Aminopeptidase N (CD13) as a target for cancer chemotherapy.
Wickström M, Larsson R, Nygren P, Gullbo J. Wickström M, et al. Among authors: gullbo j. Cancer Sci. 2011 Mar;102(3):501-8. doi: 10.1111/j.1349-7006.2010.01826.x. Epub 2011 Jan 30. Cancer Sci. 2011. PMID: 21205077 Free PMC article. Review.
Screening for apoptosis--classical and emerging techniques.
Lövborg H, Gullbo J, Larsson R. Lövborg H, et al. Among authors: gullbo j. Anticancer Drugs. 2005 Jul;16(6):593-9. doi: 10.1097/00001813-200507000-00001. Anticancer Drugs. 2005. PMID: 15930885 Review.
Melflufen for relapsed and refractory multiple myeloma.
Oriol A, Larocca A, Leleu X, Hajek R, Hassoun H, Rodríguez-Otero P, Paner A, Schjesvold FH, Gullbo J, Richardson PG. Oriol A, et al. Among authors: gullbo j. Expert Opin Investig Drugs. 2020 Oct;29(10):1069-1078. doi: 10.1080/13543784.2020.1808884. Epub 2020 Sep 29. Expert Opin Investig Drugs. 2020. PMID: 32924646
76 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback